M Kaye Kramer1, Donald M Molenaar, Vincent C Arena, Elizabeth M Venditti, Rebecca J Meehan, Rachel G Miller, Karl K Vanderwood, Yvonne Eaglehouse, Andrea M Kriska. 1. From the Department of Epidemiology (Drs Kramer, Kriska, and Vanderwood, Ms Meehan, Ms Miller, and Ms Eaglehouse), University of Pittsburgh Graduate School of Public Health, Pa; Department of Medicine (Dr Molenaar), Veterans Health Administration, Minneapolis, Minn; Department of Biostatistics (Dr Arena), University of Pittsburgh Graduate School of Public Health; and Western Psychiatric Institute and Clinic (Dr Venditti), Pittsburgh, Pa.
Abstract
OBJECTIVE: To determine whether an evidence-based, behavioral lifestyle intervention program delivered at a worksite setting is effective in improving type 2 diabetes and cardiovascular disease risk factors. METHODS: A randomized 6-month delayed control design was utilized, with two thirds of the participants assigned to begin intervention immediately, and one third beginning 6 months later. The year-long program (weekly for 3 months transitioning to monthly) focused on weight loss and increasing physical activity. RESULTS: The immediate intervention group had greater mean weight loss (-10.4 lb, 5.1%, vs -2.3 lb, 1%; P = 0.0001) than the delayed control group at 6 months and relatively greater improvements in activity, HbA1c, and other risk factors. The delayed group experienced similar improvements after completing the intervention program. CONCLUSIONS: A worksite behavioral lifestyle intervention is feasible and effective in significantly improving risk factors for type 2 diabetes and cardiovascular disease.
RCT Entities:
OBJECTIVE: To determine whether an evidence-based, behavioral lifestyle intervention program delivered at a worksite setting is effective in improving type 2 diabetes and cardiovascular disease risk factors. METHODS: A randomized 6-month delayed control design was utilized, with two thirds of the participants assigned to begin intervention immediately, and one third beginning 6 months later. The year-long program (weekly for 3 months transitioning to monthly) focused on weight loss and increasing physical activity. RESULTS: The immediate intervention group had greater mean weight loss (-10.4 lb, 5.1%, vs -2.3 lb, 1%; P = 0.0001) than the delayed control group at 6 months and relatively greater improvements in activity, HbA1c, and other risk factors. The delayed group experienced similar improvements after completing the intervention program. CONCLUSIONS: A worksite behavioral lifestyle intervention is feasible and effective in significantly improving risk factors for type 2 diabetes and cardiovascular disease.
Authors: H Florez; M G Temprosa; T J Orchard; K J Mather; S M Marcovina; E Barrett-Connor; E Horton; C Saudek; X F Pi-Sunyer; R E Ratner; R B Goldberg Journal: Diabetes Obes Metab Date: 2013-10-29 Impact factor: 6.577
Authors: Trevor J Orchard; Marinella Temprosa; Ronald Goldberg; Steven Haffner; Robert Ratner; Santica Marcovina; Sarah Fowler Journal: Ann Intern Med Date: 2005-04-19 Impact factor: 25.391
Authors: X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard Journal: Diabetes Care Date: 1997-04 Impact factor: 19.112
Authors: Dina Hafez; Allison Fedewa; Margaret Moran; Matthew O'Brien; Ronald Ackermann; Jeffrey T Kullgren Journal: Curr Diab Rep Date: 2017-02 Impact factor: 4.810
Authors: Mark G Wilson; David M DeJoy; Robert J Vandenberg; Phaedra Corso; Heather Padilla; Heather Zuercher Journal: J Occup Environ Med Date: 2016-11 Impact factor: 2.162
Authors: Yvonne L Eaglehouse; Gerald L Schafer; Vincent C Arena; M Kaye Kramer; Rachel G Miller; Andrea M Kriska Journal: Qual Life Res Date: 2016-02-20 Impact factor: 4.147
Authors: Yvonne L Eaglehouse; Elizabeth M Venditti; M Kaye Kramer; Vincent C Arena; Karl K Vanderwood; Bonny Rockette-Wagner; Andrea M Kriska Journal: Transl Behav Med Date: 2017-12 Impact factor: 3.046
Authors: Andrea M Kriska; Susan M Devaraj; Kaye Kramer; Jenna M Napoleone; Bonny Rockette-Wagner; Yvonne Eaglehouse; Vincent C Arena; Rachel G Miller Journal: Am J Prev Med Date: 2022-01-12 Impact factor: 5.043
Authors: Lisa G Rosas; Nan Lv; Lan Xiao; Megan A Lewis; Patricia Zavella; M Kaye Kramer; Veronica Luna; Jun Ma Journal: Contemp Clin Trials Date: 2016-03-16 Impact factor: 2.226
Authors: Richard I Stein; Jaime R Strickland; Rachel G Tabak; Ann Marie Dale; Graham A Colditz; Bradley A Evanoff Journal: Contemp Clin Trials Date: 2019-01-19 Impact factor: 2.226
Authors: Yvonne L Eaglehouse; Bonny Rockette-Wagner; M Kaye Kramer; Vincent C Arena; Rachel G Miller; Karl K Vanderwood; Andrea M Kriska Journal: Transl J Am Coll Sports Med Date: 2016-06-01